SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000077
Filing Date
2023-03-29
Accepted
2023-03-29 09:29:14
Documents
15
Period of Report
2023-03-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230329.htm   iXBRL 8-K 30050
2 EX-99.1 narcanotcapprovalpressre.htm EX-99.1 8000
6 narcanotcapprovalpressre001.jpg GRAPHIC 308934
7 narcanotcapprovalpressre002.jpg GRAPHIC 162078
  Complete submission text file 0001367644-23-000077.txt   823301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230329.xsd EX-101.SCH 1965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230329_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230329_pre.xml EX-101.PRE 13100
9 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230329_htm.xml XML 4436
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23772146
SIC: 2834 Pharmaceutical Preparations